The COVID-19 era reshaped the pharmaceutical industry, bringing new challenges and opportunities in global healthcare. At Reign, we embraced this shift by intensifying our global expansion efforts. Our International Business Division has since grown rapidly, forming partnerships across Asia, MENA, Africa, CIS, and the Caribbean.